Cargando…

The use of nanocrystalline cellulose for the binding and controlled release of drugs

The objective of this work was to investigate the use of nanocrystalline cellulose (NCC) as a drug delivery excipient. NCC crystallites, prepared by an acid hydrolysis method, were shown to have nanoscopic dimensions and exhibit a high degree of crystallinity. These crystallites bound significant qu...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, John K, Letchford, Kevin, Wasserman, Benjamin Z, Ye, Lucy, Hamad, Wadood Y, Burt, Helen M
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044185/
https://www.ncbi.nlm.nih.gov/pubmed/21383857
http://dx.doi.org/10.2147/IJN.S16749
_version_ 1782198698836492288
author Jackson, John K
Letchford, Kevin
Wasserman, Benjamin Z
Ye, Lucy
Hamad, Wadood Y
Burt, Helen M
author_facet Jackson, John K
Letchford, Kevin
Wasserman, Benjamin Z
Ye, Lucy
Hamad, Wadood Y
Burt, Helen M
author_sort Jackson, John K
collection PubMed
description The objective of this work was to investigate the use of nanocrystalline cellulose (NCC) as a drug delivery excipient. NCC crystallites, prepared by an acid hydrolysis method, were shown to have nanoscopic dimensions and exhibit a high degree of crystallinity. These crystallites bound significant quantities of the water soluble, ionizable drugs tetratcycline and doxorubicin, which were released rapidly over a 1-day period. Cetyl trimethylammonium bromide (CTAB) was bound to the surface of NCC and increased the zeta potential in a concentration-dependent manner from −55 to 0 mV. NCC crystallites with CTAB-modified surfaces bound significant quantities of the hydrophobic anticancer drugs docetaxel, paclitaxel, and etoposide. These drugs were released in a controlled manner over a 2-day period. The NCC-CTAB complexes were found to bind to KU-7 cells, and evidence of cellular uptake was observed.
format Text
id pubmed-3044185
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-30441852011-03-07 The use of nanocrystalline cellulose for the binding and controlled release of drugs Jackson, John K Letchford, Kevin Wasserman, Benjamin Z Ye, Lucy Hamad, Wadood Y Burt, Helen M Int J Nanomedicine Original Research The objective of this work was to investigate the use of nanocrystalline cellulose (NCC) as a drug delivery excipient. NCC crystallites, prepared by an acid hydrolysis method, were shown to have nanoscopic dimensions and exhibit a high degree of crystallinity. These crystallites bound significant quantities of the water soluble, ionizable drugs tetratcycline and doxorubicin, which were released rapidly over a 1-day period. Cetyl trimethylammonium bromide (CTAB) was bound to the surface of NCC and increased the zeta potential in a concentration-dependent manner from −55 to 0 mV. NCC crystallites with CTAB-modified surfaces bound significant quantities of the hydrophobic anticancer drugs docetaxel, paclitaxel, and etoposide. These drugs were released in a controlled manner over a 2-day period. The NCC-CTAB complexes were found to bind to KU-7 cells, and evidence of cellular uptake was observed. Dove Medical Press 2011 2011-02-10 /pmc/articles/PMC3044185/ /pubmed/21383857 http://dx.doi.org/10.2147/IJN.S16749 Text en © 2011 Jackson et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Jackson, John K
Letchford, Kevin
Wasserman, Benjamin Z
Ye, Lucy
Hamad, Wadood Y
Burt, Helen M
The use of nanocrystalline cellulose for the binding and controlled release of drugs
title The use of nanocrystalline cellulose for the binding and controlled release of drugs
title_full The use of nanocrystalline cellulose for the binding and controlled release of drugs
title_fullStr The use of nanocrystalline cellulose for the binding and controlled release of drugs
title_full_unstemmed The use of nanocrystalline cellulose for the binding and controlled release of drugs
title_short The use of nanocrystalline cellulose for the binding and controlled release of drugs
title_sort use of nanocrystalline cellulose for the binding and controlled release of drugs
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044185/
https://www.ncbi.nlm.nih.gov/pubmed/21383857
http://dx.doi.org/10.2147/IJN.S16749
work_keys_str_mv AT jacksonjohnk theuseofnanocrystallinecelluloseforthebindingandcontrolledreleaseofdrugs
AT letchfordkevin theuseofnanocrystallinecelluloseforthebindingandcontrolledreleaseofdrugs
AT wassermanbenjaminz theuseofnanocrystallinecelluloseforthebindingandcontrolledreleaseofdrugs
AT yelucy theuseofnanocrystallinecelluloseforthebindingandcontrolledreleaseofdrugs
AT hamadwadoody theuseofnanocrystallinecelluloseforthebindingandcontrolledreleaseofdrugs
AT burthelenm theuseofnanocrystallinecelluloseforthebindingandcontrolledreleaseofdrugs
AT jacksonjohnk useofnanocrystallinecelluloseforthebindingandcontrolledreleaseofdrugs
AT letchfordkevin useofnanocrystallinecelluloseforthebindingandcontrolledreleaseofdrugs
AT wassermanbenjaminz useofnanocrystallinecelluloseforthebindingandcontrolledreleaseofdrugs
AT yelucy useofnanocrystallinecelluloseforthebindingandcontrolledreleaseofdrugs
AT hamadwadoody useofnanocrystallinecelluloseforthebindingandcontrolledreleaseofdrugs
AT burthelenm useofnanocrystallinecelluloseforthebindingandcontrolledreleaseofdrugs